A recent targeted resequencing study conducted on patients with severe hypertriglyceridemia (HTG) for APOA5 detected an abundance of rare variants in HTG patients with T2D in comparison to those without T2D (25% vs. 6.1%, p = 0.037) [33]. The gene discussed is APOA5; the disease is hypertriglyceridemia.